Cargando…

Correction: Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells

Detalles Bibliográficos
Autores principales: Krug, Sebastian, Mordhorst, Jan-Philipp, Moser, Fabian, Theuerkorn, Katharina, Ruffert, Claudia, Egidi, Maren, Rinke, Anja, Gress, Thomas M., Michl, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6999902/
https://www.ncbi.nlm.nih.gov/pubmed/32017803
http://dx.doi.org/10.1371/journal.pone.0228905
_version_ 1783493980553478144
author Krug, Sebastian
Mordhorst, Jan-Philipp
Moser, Fabian
Theuerkorn, Katharina
Ruffert, Claudia
Egidi, Maren
Rinke, Anja
Gress, Thomas M.
Michl, Patrick
author_facet Krug, Sebastian
Mordhorst, Jan-Philipp
Moser, Fabian
Theuerkorn, Katharina
Ruffert, Claudia
Egidi, Maren
Rinke, Anja
Gress, Thomas M.
Michl, Patrick
author_sort Krug, Sebastian
collection PubMed
description
format Online
Article
Text
id pubmed-6999902
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-69999022020-02-18 Correction: Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells Krug, Sebastian Mordhorst, Jan-Philipp Moser, Fabian Theuerkorn, Katharina Ruffert, Claudia Egidi, Maren Rinke, Anja Gress, Thomas M. Michl, Patrick PLoS One Correction Public Library of Science 2020-02-04 /pmc/articles/PMC6999902/ /pubmed/32017803 http://dx.doi.org/10.1371/journal.pone.0228905 Text en © 2020 Krug et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Krug, Sebastian
Mordhorst, Jan-Philipp
Moser, Fabian
Theuerkorn, Katharina
Ruffert, Claudia
Egidi, Maren
Rinke, Anja
Gress, Thomas M.
Michl, Patrick
Correction: Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells
title Correction: Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells
title_full Correction: Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells
title_fullStr Correction: Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells
title_full_unstemmed Correction: Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells
title_short Correction: Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells
title_sort correction: interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6999902/
https://www.ncbi.nlm.nih.gov/pubmed/32017803
http://dx.doi.org/10.1371/journal.pone.0228905
work_keys_str_mv AT krugsebastian correctioninteractionbetweensomatostatinanaloguesandtargetedtherapiesinneuroendocrinetumorcells
AT mordhorstjanphilipp correctioninteractionbetweensomatostatinanaloguesandtargetedtherapiesinneuroendocrinetumorcells
AT moserfabian correctioninteractionbetweensomatostatinanaloguesandtargetedtherapiesinneuroendocrinetumorcells
AT theuerkornkatharina correctioninteractionbetweensomatostatinanaloguesandtargetedtherapiesinneuroendocrinetumorcells
AT ruffertclaudia correctioninteractionbetweensomatostatinanaloguesandtargetedtherapiesinneuroendocrinetumorcells
AT egidimaren correctioninteractionbetweensomatostatinanaloguesandtargetedtherapiesinneuroendocrinetumorcells
AT rinkeanja correctioninteractionbetweensomatostatinanaloguesandtargetedtherapiesinneuroendocrinetumorcells
AT gressthomasm correctioninteractionbetweensomatostatinanaloguesandtargetedtherapiesinneuroendocrinetumorcells
AT michlpatrick correctioninteractionbetweensomatostatinanaloguesandtargetedtherapiesinneuroendocrinetumorcells